Search filters

List of works by Andrés J M Ferreri

A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the "CARMEN" phase II trial

scientific article published on 21 October 2020

A virtual tissue bank for primary central nervous system lymphomas in immunocompetent individuals

scientific article

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?

scientific article

Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications

scientific article published on March 2006

BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome

scientific article published on 13 January 2009

Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial

scientific article published on October 2006

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

scientific article published on 23 January 2013

Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods

scientific article

Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial.

scientific article published on 16 July 2012

Clarithromycin as a "repurposing drug" against MALT lymphoma.

scientific article

Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma

scientific article published on 29 February 2016

Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma

scientific article

Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms

scientific article published on 01 February 2022

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome.

scientific article

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

scientific article

Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas.

scientific article published on April 2004

Gains of CCND3 gene in ocular adnexal MALT lymphomas: an integrated analysis

scientific article

Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP

Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice

scientific article published on 9 October 2012

Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

scientific article published on 29 November 2010

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

scientific article published on 31 August 2010

Genomic profiles of MALT lymphomas: variability across anatomical sites

scientific article

Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations

scientific article published on 26 September 2017

Integrated profiling of diffuse large B-cell lymphoma with 7q gain

scientific article published on 21 March 2011

Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation

scientific article published on 01 May 2020

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Pr

scientific article published on 28 February 2013

Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma.

scientific article published on 2 May 2018

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

scientific article

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

scientific article published on 28 August 2012

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries

scientific article

Prevention of CNS relapse in diffuse large B-cell lymphoma: common sense prevails where science fails

scientific article published on 12 May 2020

Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy

scientific article published on 7 August 2015

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma

scientific article

Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.

scientific article published on 12 November 2015

R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma

scientific article published on 22 May 2019

Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy

scientific article published on 20 June 2005

RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.

scientific article published on 08 December 2016

Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa

scientific article published on 01 November 2005

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

scientific article published on 17 May 2019

Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program

scientific article published on 20 March 2013

Paulina is supported by:

About Paulina

Help